Traditional computer-aided drug design (CADD) helps researchers screen for potential new drug-like molecules and predict their biological activity before completing laboratory experiments.

The potential of using artificial intelligence in drug discovery and development has sparked both excitementand skepticism ...

Over a video call, Alex Zhavoronkov holds up a small, green, diamond-shaped pill. It has been developed by his company to ...

The inaugural Structure-Based Drug Design Summit is your opportunity to assess the resolution and speed of the techniques in the toolbox to answer structural biology questions for drug design ...

This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at all stages of the drug discovery and design journey. Robust process ...

Its deal with the US-based AI-driven drug design and development company will see Cloud design novel small-molecule agents to GSK-specified targets. Ed Addison, CEO of Cloud Pharmaceuticals ...

from target identification and drug design to preclinical safety and beyond—and this innovation has catalyzed and will continue to catalyze new therapeutic possibilities,” said Rory Kelleher ...

These findings provide a fresh framework for understanding GPR6 function with a detailed basis for structure-based drug design, offering hope for improved future treatments of Parkinson's disease.